Deal overview

Deal overview
Target MEDICINES COMPANY (THE)
Bidder NOVARTIS AG
Price £90.00 Full version or £25.00 Light version
Publication Date Nov 24, 2019
Abstract On 24 November 2019, it was announced that the quoted Swiss pharmaceuticals group Novartis AG was to make a recommended cash offer to acquire "The Medicines Company", a Nasdaq listed pharmaceuticals business. According to the two companies, the offer of US$85 in cash per share implied a fully diluted equity value for The Medicines Company of US$9.7 billion. The tender offer ...
Number of pages (Full version) 9
Number of pages (Light version) 2
Format Adobe Acrobat (Download Acrobat Reader)
Free Sample Click Here to Download

Purchase this report

Accepted credit cards: Visa, America Express, Master Card

Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.

Search for Deals

Search over 70 million deal reports on more than 550,000 public and private companies. (copy)

Back to search results

Page Time: 0.023995s